Abstract
Nowadays radiation toxicity is relatively rare; however, patients have to be informed and closely followed up. Risk factors for radiotoxicity are doses, volume irradiated, age at exposure, time from exposure, chemotherapy, and cardiovascular risk factors. Cellular toxicity consists of an acute inflammation cell death with replacement of necrotic tissue by extensive fibrosis.
This process includes all cardiac structures. Coronary disease evolution is severe, quick, and involving proximal tracts. An acute coronary syndrome or sudden death may be the first event. Fibrosis and valvular calcification occur mainly on left-sided valves. Supraventricular and ventricular arrhythmias, sick sinus syndrome, or conduction blocks may be present. Acute pericarditis and large effusions leading to tamponade, chronic effusion, and constrictive pericarditis may develop after variable time from irradiation. The nervous system of the heart can be damaged by RT, altering pain and angina threshold and sympathovagal balance. Myocardial fibrosis leads to diastolic dysfunction with a picture of restrictive cardiomyopathy, and association to anthracyclines can evolve with a systolic dysfunction. Heart failure may be aggravated by concomitant valve and coronary disease. Also great vessels of the neck and other body regions may be involved.
Treatment of radiation-induced diseases is similar to that of the same not radiation-induced clinical expressions, but surgical procedures like a surgical pericardial window, a coronary bypass procedure, or a valve replacement may be very difficult for intense mediastinal fibrosis. Coronary revascularization through interventional cardiology and TAVI may be preferable.
An adequate follow-up of patients submitted to RT is mandatory but is still lacking clear recommendations about timing and method.
The reduction of possible radiation-induced cardiotoxicity may be obtained lowering the dose of radiation and the cardiac volume exposed with different methods requiring sophisticated technologies based on advanced imaging analyses and complex radiation delivery tools.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Lipshultz SE. AHA scientific statement – long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions. Circulation. 2013;128:1927.
Yeh ETH. Cardiovascular complications of cancer therapy. Diagnosis, pathogenesis and management. Circulation. 2004;109:3122.
Adams MJ. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol. 2003;45:55.
Adams MJ. Radiation-associated cardiovascular disease: manifestation and management. Semin Radiat Oncol. 2003;13:346.
Chello M. Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis. Cardiovasc Surg. 1996;4:222.
Stewart JR. Radiation injury to the heart. Int J Radiat Oncol Biol Phys. 1995;31:1205.
Robbins ME. Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol. 2004;80:251.
Hendry JH. Radiation-induced cardiovascular injury. Radiat Environ Biophys. 2008;47:189.
Lipsultz SE. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J Clin Oncol. 2012;30:1050.
Brosius 3rd FC. Radiation heart disease: analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med. 1981;70:519.
Stewart JR. Radiation-induced heart disease: an update. Prog Cardiovasc Dis. 1984;27:123.
Veinot JP. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol. 1996;27:766.
Horimoto M. Pulmonary infundibular stenosis, coronary artery disease and aortic regurgitation caused by mediastinal radiation. Am Heart J. 1993;126:100.
Mc Eniery PT. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol. 1987;60:1020.
King V. Symptomatic coronary artery disease after mantle irradiation for Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 1996;36:881.
Joensuu H. Myocardial infarction after irradiation on Hodgkin’s disease: a review. Recent Results Cancer Res. 1993;130:157.
Amromin GD. The Synergism of x-irradiation and cholesterol-fat feeding on the development of coronary artery lesions. J Atheroscler Res. 1964;4:325.
Fajardo LF. Radiation-induced coronary artery disease. Chest. 1977;71:563.
Lindsay S. Aortic arteriosclerosis in the dog after localized aortic x-irradiation. Circ Res. 1962;10:51.
Bradley EW. Coronary arteriosclerosis and atherosclerosis in fast neutron or photon irradiated dogs. Int J Radiat Oncol Biol Phys. 1981;7:1103.
Artom C. Ionizing radiation, atherosclerosis and lipid metabolism in pigeons. Radiat Res. 1965;26:165.
Acker JC. Serial in vivo observation of cerebral vasculature after treatment with a large single fraction of radiation. Radiat Res. 1998;149:350.
Yuan H. Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation and ultrastructural changes. Int J Radiat Oncol Biol Phys. 2006;66:860.
Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol. 2005;44:13.
Orzan F. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J. 1993;69:496.
Gyenes G. Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy. Eur J Nucl Med. 1997;24:286.
Cheng SW. Carotid stenosis after radiotherapy for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2000;126:517.
Hancock SL. Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. JAMA. 1993;270:1949.
Carmel RJ. Mantle irradiation in Hodgkin’s disease: an analysis of technique, tumour eradication and complications. Cancer. 1976;37:2813.
Maraldo MV. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2012;83:1232.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Asteggiano, R. (2015). Radiotherapy Heart Effects. In: Baron Esquivias, G., Asteggiano, R. (eds) Cardiac Management of Oncology Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-15808-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-15808-2_3
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15807-5
Online ISBN: 978-3-319-15808-2
eBook Packages: MedicineMedicine (R0)